Hint mode is switched on Switch off

TheraCryf, ordinary share
TCF, GB00BSVYN304

Add a stock to WL
Choose all Reset all
TheraCryf, сountry — United Kingdom
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
TheraCryf plc is a clinical stage therapeutics company developing a new generation of innovative therapeutics in oncology and behavioural brain disorders. TheraCryf’s strategy is to generate compelling data sets with a goal of partnering its programmes ...
TheraCryf plc is a clinical stage therapeutics company developing a new generation of innovative therapeutics in oncology and behavioural brain disorders. TheraCryf’s strategy is to generate compelling data sets with a goal of partnering its programmes with mid-size to large pharma.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    TheraCryf plc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Indicators

News

17/07/2025 TheraCryf: Manufacturing Scale Up of Lead Ox-1 Programme
09/07/2025 TheraCryf: Result of AGM
09/07/2025 TheraCryf: AGM Statement
16/06/2025 TheraCryf: Notice of AGM
13/06/2025 TheraCryf: Change of Adviser
All organization news

Holders

Industry Leaders

Registration is required to get access.